Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/23218| Title: | Exploiting the Full Potential of Beta-Amyloid and Tau PET Imaging for Drug Efficacy Testing. | Austin Authors: | Barthel, Henryk;Seibyl, John;Lammertsma, Adriaan A;Villemagne, Victor L ;Sabri, Osama | Affiliation: | Leipzig University, Germany Institute for Neurodegenerative Disorders VU University Medical Center Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia University Hospital Leipzig |
Issue Date: | 15-May-2020 | Date: | 2020-05-15 | Publication information: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2020; online first: 15 May | URI: | https://ahro.austin.org.au/austinjspui/handle/1/23218 | DOI: | 10.2967/jnumed.119.228346 | ORCID: | 0000-0002-5832-9875 | Journal: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine | PubMed URL: | 32414946 | Type: | Journal Article | Subjects: | Alzheimer Amyloid Drugs Neurology PET Tau |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.